Healthcare >> CEO Interviews >> June 12, 2000
DAVID CHISWELL BSc PhD, is the Chief Executive Officer of Cambridge
Antibody Technology Group Plc. A founder of CAT, David Chiswell has
been responsible for the operational management of CAT from its
inception. He joined the Board in December 1995 and took on the role of
Chief Executive Officer in 1996. Prior to CAT he spent nine years at
Amersham International Plc where his main responsibilities included
product development and research management. David's research experience
was gained at the MRC Institute of Virology in Glasgow, the department
of Immunology and Microbiology at UCLA, California and in the department
of Tumour Virology at the Imperial Cancer Research Fund in London. Profile
where you stand today?
Dr. Chiswell: Cambridge Antibody Technology was founded in 1990, we had
our London Stock Exchange
